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Background and Purpose 
In acute ischemic stroke, the Hyperdense Artery Sign (HAS) on non-contrast CT is 
thought to represent intra-luminal thrombus and therefore is a surrogate of arterial 
obstruction.  We sought to assess the accuracy of HAS as a marker of arterial 
obstruction by thrombus.   
 
Methods 
The Third International Stroke Trial (IST-3) was a randomized controlled trial testing 
use of intravenous thrombolysis for acute ischemic stroke in patients who did not 
clearly meet the prevailing license criteria.  Some participating IST-3 centers 
routinely performed CT or MR angiography (CTA and MRA, respectively) at baseline.  
One reader assessed all relevant scans independently, blinded to all other data; we 
checked observer reliability.  We combined IST-3 data with a systematic review and 
meta-analysis of all studies that assessed the accuracy of HAS using angiography (any 
modality).   
 
Results 
IST-3 had 273 patients with baseline CTA or MRA and was the largest study of HAS 
accuracy.  The meta-analysis (n=902+273=1175, including IST-3) found sensitivity and 
specificity of HAS for arterial obstruction on angiography to be 52% and 95%, 
respectively.  HAS was more commonly identified in proximal than distal arteries 
(47% versus 37%, p=0.015), and its sensitivity increased with thinner CT slices (r=-
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When present in acute ischemic stroke, HAS indicates a high likelihood of arterial 
obstruction, but its absence indicates only a 50/50 chance of normal arterial 
patency.  Thin-slice CT improves sensitivity of HAS detection. 
 
Clinical Trial Registration Information 
URL: http://www.controlled-trials.com/ISRCTN25765518 









Non-contrast CT remains the primary imaging modality for hyperacute assessment of 
stroke in most centers1.  Identifying features of acute ischemic stroke on CT 
therefore remains important for routine practice.  Hyper-attenuation of a cerebral 
artery on non-contrast CT in acute ischemic stroke is thought to represent acute 
thrombus or embolus; the presence of the Hyperdense Artery Sign (HAS) therefore is 
a surrogate of arterial obstruction and may provide useful confirmation of the 
diagnosis of acute ischemic stroke.  The sign has been defined as any artery that 
subjectively appears transiently denser than adjacent or equivalent contralateral 
vessels2,3 although objective measures have also been applied4.  Compared with 
angiography, previous studies have shown that the HAS is a specific (although false 
positives are described5) but not very sensitive indicator of arterial obstruction6,7.  To 
our knowledge, no systematic review and meta-analysis of HAS sensitivity and 
specificity has been published. 
 
The Third International Stroke Trial (IST-3) was a multi-center, randomized controlled 
trial which tested intravenous thrombolysis (Alteplase) given within 6 hours of 
ischemic stroke8.  Baseline (pre-randomization) and follow-up (within 48 hours) brain 
imaging (predominantly non-contrast CT) was performed for all IST-3 patients 
(n=3035).  In some centers, CT or MR angiography (CTA and MRA, respectively) were 
also routinely obtained pre-randomization as part of their local stroke imaging 




In a prespecified analysis, we investigated the diagnostic accuracy of HAS for arterial 
obstruction detected with CTA or MRA and assessed if characteristics of the non-
contrast CT scan (slice thickness), the corresponding angiographic obstruction 
(location, extent), or the patient (time from stroke onset) affected the accuracy of 
HAS.  We examined data from IST-3 and performed a systematic review and meta-






Third International Stroke Trial 
IST-3 was an international, multi-center, prospective, randomized, open, blinded 
endpoint (PROBE) trial of intravenous rt-PA (recombinant tissue plasminogen 
activator) in acute ischemic stroke.  Ethical approval, enrolment and data collection 
were described elsewhere10.  Briefly, patients with acute stroke of any severity, with 
no upper age limit, were eligible for trial inclusion if, in the opinion of the 
responsible physician the patient might benefit from rt-PA and there was no clear 
indication for or contraindication to rt-PA, if intravenous rt-PA could be started 
within 6 hours of stroke onset and CT/MR imaging had reliably excluded both 
intracranial hemorrhage and any structural stroke mimic.  In other words, patients 
who definitely met the prevailing strict license criteria, or who had definite 
contraindications to rt-PA were not eligible.  Many patients fell outside the strict 
license criteria and did not have definite contraindications and therefore could be 
randomized in the trial.  Stroke severity prior to randomization was assessed with 
the National Institutes of Health Stroke Scale (NIHSS).  Patients were randomized to 
receive intravenous rt-PA (0.9mg/Kg) or control.  No intra-arterial therapy was used.  
Functional status was assessed at six-months with the Oxford Handicap Scale (OHS).  
IST-3 is registered, ISRCTN25765518. 
 
The imaging protocol required that non-contrast CT scans extend from the foramen 
magnum to vertex, with maximum slice thickness 4-5mm through the posterior fossa 
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and 8-10mm for the cerebral hemispheres.  There was no pre-defined requirement 
for thin-slice sections but all acquired data including spiral volumes were accepted.   
 
CTA or MRA data were also collected if available; the protocol for the IST-3 
angiography substudy specified minimum acquisition standards11.  Only IST-3 
patients who had CTA or MRA performed concurrently with baseline non-contrast CT 
are included in this present analysis.  
 
All centers had to submit test imaging to the IST-3 central office for quality 
assessment prior to being certified to join the trial. 
 
Image analysis 
A single neuroradiologist evaluated all relevant IST-3 images analysing first the non-
contrast CT followed by CTA or MRA sequentially and independently, blinded to any 
subsequent imaging or other scan reads, clinical and treatment data, using a 
validated, pre-specified rating proforma (see: 
www.sbirc.ed.ac.uk/research/imageanalysis.html) that recorded presence, location, 
extent of HAS and any angiographic obstruction9,11. 
 
Standard brain window settings (center 40 Hounsfield Units [HU], width 80 HU) were 
used for non-contrast CT analysis but these could be altered as required.  We 
identified HAS on non-contrast CT if the lumen of any intracranial artery appeared 
more dense than adjacent or equivalent contralateral arteries but non-calcified.  
Thin-slice sections were used where possible to minimize volume averaging of any 
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arterial wall calcification.  We classified the internal carotid, mainstem of middle 
cerebral, vertebral and basilar arteries as ‘proximal’ and the sylvian branches of 
middle cerebral and any part of the anterior or posterior cerebral arteries as ‘distal’ 
for analysis purposes. We classified arterial obstruction on CTA/MRA using a 
modified 4 point Thrombolysis in Cerebral Infarction (TICI) score9,11.  
 
To assess intra-observer reliability of HAS and CTA/MRA, the single neuroradiologist 
repeated ratings of 15 randomly selected patients at least 2 months later. To assess 
inter-observer reliability, we compared the single neuroradiologist to the ratings 
performed by the IST-3 expert image reading panel performed separately using the 
same analysis method11 (details of expert panel are provided in online Appendix II; 
these expert panel reads were not otherwise used in this present analysis). 
 
Systematic Review and Meta-Analysis 




We searched Embase and Medline (see online Table I for full strategy) between 1980 
and September 2013, since HAS was first described in the early 1980s2, including 
hand searching references of returned papers. 
 
Inclusion/exclusion criteria and data extraction  
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We screened abstracts for more in-depth assessment and included only peer-
reviewed original articles, published in English, that contained data on ischemic 
stroke patients assessed for HAS who underwent invasive or non-invasive 
angiography.   
 
We assessed study quality for secondary eligibility criteria, using a modified STARD 
checklist13 (online Table II).  We excluded articles if imaging was performed >24 
hours after stroke onset (limit chosen to include articles assessing posterior fossa 
HAS) or if <20 patients underwent CT-, MR-, or digital subtraction angiography. 
 
Two observers independently extracted data to calculate true and false positive and 
negative rates.  We only meta-analysed papers where sensitivity or specificity 
(ideally both) could be calculated.  We also recorded time from stroke onset to 
imaging, location and/or extent of angiographic obstruction.  Disagreements were 
resolved by consensus. 
 
Statistics 
We compared clinical characteristics of the IST-3 patients with angiography to all IST-
3 patients using t-tests, Mann-Whitney U tests, or Chi-squared tests as appropriate. 
We assessed observer reliability using the Kappa statistic.  We used Spearman’s rank 
correlation coefficient to assess correlations between normally distributed 
continuous data and t-tests to compare ratios of patients with and without HAS in 




For simplicity in the present analysis and to harmonise angiographic scoring between 
papers, we dichotomised angiography as ‘normal’ or ‘obstructed’ (i.e. any luminal 
narrowing or occlusion).  We compared the angiography location of arterial 
obstruction with the HAS location, noting false positives and negatives.  
 
We calculated sensitivity (true positives/[true positives plus false negatives]), 
specificity (true negatives/[true negatives plus false positives]) in individual studies.  
We meta-analysed sensitivity and specificity with a random effects model in R2.8.1 
(http://cran.r-project.org/), using the DiagMeta function, modelling within-study 
variation as a binomial proportion14 (joint meta-analysis of sensitivity and specificity 
was not possible due to estimation problems). 
  
Unless stated otherwise, all analyses were performed using SPSS Statistics software, 








In total, 273 IST-3 patients (9% of the total of 3035) had baseline CTA (n=269) or 
MRA (n=4).  Patients with (versus without) angiography had very similar baseline 
characteristics, but less severe strokes (median NIHSS 10 versus 11, p=0.020) and 
better 6-month outcomes (median OHS 3 versus 4, p=0.002); online Table III.   
 
Of the 273 IST-3 patients with angiography, 114 (42%) had some degree of luminal 
obstruction on angiography while 69 (25%) had a HAS.   
 
Inter- and intra-observer reliability (Kappa) for identification of HAS was 0.59 and 
0.58, respectively; for any versus no obstruction on angiography was 0.59 and 0.82, 
respectively. 
 
Reliability of HAS versus angiography in IST-3 
In IST-3, HAS correctly identified arterial obstruction in 62, was falsely positive in 7 
and falsely negative in 52, giving a sensitivity of 54% (95% CI 45-64%) and a 
specificity of 96% (92-99%).   
 
Sensitivity, but not specificity, improved with thinner baseline non-contrast CT scan 
slices: ≤3mm slices, n=162, sensitivity 62%, specificity 98%; versus >3mm slices, 
n=108, sensitivity 41%, specificity 92%, (p=0.031, p=0.089, respectively).  There was 
no difference in the prevalence of HAS by location of arterial obstruction: proximal 
n=91, sensitivity 55% versus distal, n=23, sensitivity 52% (p=0.814).  More extensive 
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angiographic obstruction, i.e. involving more than one named artery (n=48) versus 
obstruction of one named artery (n=66), did not influence sensitivity of HAS (58% 
versus 52%, p=0.475).  Time from stroke onset did not alter the accuracy of HAS: 
patients scanned ≤180 minutes (n=151) sensitivity 49%, specificity 97% versus 
patients scanned >180 minutes (n=122), sensitivity 61% (p=0.221), specificity 94% 
(p=0.500).  
 
Systematic review, results of search 
We identified 326 papers by database search: 75% discussed non-intracranial HAS; 
10% were published only in abstract; 10% were review articles or non-English 
language; online Figure I.  Thirty one articles underwent more in-depth assessment 
plus 5 further articles were found in reference lists, giving a total of 36 articles for 
full review.  After secondary exclusion criteria, 16/36 original articles (n=902, Figure 
1) remained for meta-analysis6,7,15-28.  Twenty articles were excluded: 7 provided 
insufficient raw data; 6 had <20 patients with angiography; 2 failed essential quality 
criteria; 2 were duplicates; 2 included patients imaged >24 hours after stroke; 1 
included non-ischemic strokes. 
 
Quality assessment 
The 16 papers identified in systematic review (n=902, not including IST-3) had a 
median of 52 patients (range 20-105); most (14/16, 88%) were prospective, only 7 
(44%) provided specific inclusion and/or exclusion criteria and none included data 




Most papers provided scan parameters and time from stroke onset to scan (15/16, 
94% in both cases).  Catheter angiography was the commonest technique (9/16, 
56%); CTA and MRA were equally common (5/16, 31%, 4/16, 25%, respectively) and 
used almost exclusively since 2003.  Most articles declared the experience or 
professional position of those analysing images (14/16, 88%); with 24 
neuroradiologists and 9 neurologists in the range of 1-6 observers per article 
(median 2).  Image assessors were blinded to other data in 11/16 (69%) papers, 
12/16 (75%) papers used a standardized definition for HAS, only 4 papers assessed 
reproducibility of HAS (median kappa-statistic for HAS detection 0.85, range 0.53-
0.91) and no papers assessed reproducibility of angiography. 
 
Meta-analysis  
Amongst a total of 1175 patients with angiography including IST-3, 769 had arterial 
obstruction, and 405 had a HAS (Figure 1).  The random effects summary estimate of 
sensitivity, based on 771 patients (384 true positive plus 387 false negative), was 
52.4% (95% CI 41.2-63.4%).  The random effects summary estimate of specificity, 
based on 493 patients, (468 true negative plus 25 false positive), was 94.9% (92.5-
96.6%).  Four studies with missing data were omitted from specificity analysis.  
 
HAS was more common with angiographic obstruction in proximal arteries than 
distal (47% versus 37%, p=0.015), Table 1.  CT slice thickness was significantly 
associated with sensitivity (Figure 2, r=-0.72, p=0.002) but not specificity of HAS, and 
was inversely proportional to the year of article publication (r=-0.80, p=0.001, Figure 
1).  The number of obstructed arterial segments (59% had HAS if ≥2 segments 
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obstructed versus 49% if 1 segment obstructed, p=0.160) and time from stroke onset 
to scan (27% had HAS if ≤180 minutes from stroke onset versus 25% if >180 minutes, 
p=0.682), were not associated with HAS prevalence.  Three studies with missing data 







We provide this first meta-analysis assessing the accuracy of HAS as a non-contrast 
CT marker of arterial obstruction in acute ischemic stroke and confirm using large 
patient numbers, that HAS is highly specific and moderately sensitive for 
angiographically demonstrated arterial obstruction with overall specificity 95% and 
sensitivity 52%.  IST-3, as the largest individual study of HAS sensitivity and 
specificity, contributes 30% more data (273/902 patients, new total 1175) than 
previously available.  Our results are widely applicable and in situations where 
angiographic imaging is not currently available, can enable those performing non-
contrast CT to make the best use of all available imaging information; the presence 
of HAS provides substantial confidence that there is a very high likelihood of the 
diagnosis of acute ischemic stroke and of arterial obstruction.  However, absence of 
HAS does not predict normal arterial patency; in acute ischemic stroke patients 
without HAS, approximately half will have arterial obstruction on angiography.  It 
remains to be seen whether the presence (or absence) of acute arterial obstruction 
is important for intravenous thrombolysis treatment decisions; but in that context, 
or indeed in centers looking to perform appropriate endovascular therapy, this 
limitation of a ‘negative’ HAS might encourage centers performing acute ischemic 
stroke imaging to consider providing baseline CTA or MRA in all cases. 
 
Our meta-analysis confirmed that HAS prevalence increases with thinner CT slices, 
but thinner slices have no effect on HAS specificity, perhaps as HAS is already highly 
specific for obstruction23.  The mean diameter of intracranial arteries is less than 
3mm.  A slice thickness above this value, used in most of the included studies, may 
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impair HAS sensitivity (especially in smaller arteries) by averaging intra-luminal 
thrombus and surrounding CSF space.  Volumetric thin-slice CT is now widely 
available, as suggested by the highly significant inverse relationship between year of 
publication and CT slice thickness in the systematic review.  Allowing for the rising 
availability of volumetric CT, sensitivity rates in current routine clinical practice are 
therefore likely to be on the high side of those we report here.   
 
Meta-analysis also confirmed that HAS is more likely to be identified in proximal than 
distal arteries, probably reflecting the larger calibre of proximal arteries and greater 
volumes of thrombus required for obstruction26.  Other factors such as extent of 
angiographic obstruction and time after stroke onset were not significantly related 
to HAS prevalence.  
 
Strengths and limitations 
IST-3 was conducted in many centers, so inevitably includes variability in scan 
parameters and protocols.  However, IST-3 represents ‘real world practice’ and, 
combined with the systematic review, provides results that are widely applicable to 
centers assessing acute stroke with a range of CT scanners.  Angiography in IST-3 was 
performed in about 10% of centers and may have been influenced by local practice, 
so has limitations.  Nevertheless, IST-3 angiography is the largest complete dataset 
of its kind, the only one performed in the standardized context of a randomized trial, 
and increases the available data by almost one-third.  We found only one larger 
dataset29 but it only included patients with a HAS precluding assessment of 




We used a qualitative measure to identify HAS in IST-3 which reflects routine 
practice.  Further work is ongoing to assess whether measuring intra-arterial 
thrombus density quantitatively improves accuracy for arterial obstruction or 
interacts with treatment response. 
 
Our method of dichotomizing angiography results may have included some patients 
with chronic atheroma in the ‘obstructed’ group.  This could erroneously raise the 
number of false negative HAS cases and thereby appear to reduce the sensitivity of 
HAS.  However this is a general problem in acute stroke, no other studies that we 
identified in the literature had addressed this point, and we decided that the 
opposite approach (to only consider patients with occluded arteries as abnormal) 
would have been less accurate by having the same effect on HAS specificity but also 
by excluding patients with genuine non-dense thrombus from our analyses entirely. 
 
By using PRISMA and STARD, we maintained a high quality systematic review and 
meta-analysis of HAS.  We identified many papers, most not relevant, but we assert 
that evaluating several hundred abstracts was preferable to missing relevant work.  
Excluding abstract-only and non-English publications may have reduced the 
completeness and led to publication bias, but abstract-only publication provides 
insufficient raw data for our analyses.     
 
The final 16 articles retained for meta-analysis were of moderate to high quality 
according to our criteria.  In particular, most of the data were prospective and the 
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methods were detailed enough to be replicated.  More standard definitions for HAS 
and more consistent reporting of factors such as blinding of image assessment would 
improve future research30. 
 
Conclusions 
The high specificity of HAS provides confidence for its use as a surrogate marker of 
angiographic obstruction and to confirm the diagnosis of acute ischemic stroke.  The 
moderate sensitivity means that absence of HAS cannot be used alone to indicate 
that angiography will be normal; those performing acute stroke imaging might 
therefore consider undertaking angiography in this context.  Sensitivity of HAS is 
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Figure 1.  Systematic review data for the 16 selected articles and IST-3  
 
Footnote: 
Data from individual studies was only included if at least sensitivity or specificity 
could be calculated.  Unless stated otherwise, CT slice-thickness refers to the thickest 
slices used.  CTA = CT angiography.  MRA = MR angiography. HAS = Hyperdense 
Artery Sign.  TP = True positive. TN = True negative.  FP = False positive.  FN = False 
negative.  CI = Confidence Interval. 
* One patient had both a false positive HAS and a true occlusion without HAS (FN) in 
contralateral arteries; 39 results are therefore reported from 38 angiograms. 
† Data for proximal and distal middle cerebral artery are presented separately 
providing assessment of 200 arterial segments from 100 angiograms.   
‡ Thin-slice CT data are presented.  Thick-slice (5mm) data for the same angiography 





Figure 2.  Relationship between the sensitivity of a hyperdense artery sign (HAS) for 
arterial obstruction and non-contrast CT slice thickness 
 
Footnote: 
Closed dots represent IST-3 data (thin-slice ≤3mm, mean 1.65mm; thick-slice >3mm, 
mean 4.5mm).  Open dots represent results from articles identified on systematic 
review.  Two dots have been fractionally altered to reveal identical results (sensitivity 








Table 1.  Systematic review data assessing how characteristics of arterial obstruction (location and extent) and time from stroke onset affect 









Location of Arterial Obstruction Number of Obstructed  
Arterial Segments 
Time from Stroke Onset  
to Scan (minutes) 
Proximal Distal 1 ≥2 ≤180 ≥180 
Assouline25 2005 39 8/16(50) 6/7(86) 11/17(65) 4/8(50)   
Barber22 2004 100 7/25(28) 11/24(46)     
Bastianello6 1991 36 12/17(71) 6/13(46)     
Flacke19 2000 23 6/10(60) 0/10(0)     
Froehler28 * 2013 67 15/20(75) 23/43(53)     
Garg7 2004 65     1/8(13) 8/57(14) 
Kim23 † 2005 51 11/38(29) 7/31(23)     
Kim26 2008 78 36/56(64) 10/22(45)     
Koga20 2003 105 21/63(33) 6/38(16)     
Tomsick15 1990 20 4/9(44) 2/7(29) 3/10(30) 3/6(50)   
26 
 
Tomsick16 1992 38 7/14(50) 5/12(42) 8/22(36) 6/7(86)   
von Kummer18 1994 53     20/43(47) 5/10(50) 
Wolpert17 1993 60 12/43(28) 4/17(24)     
IST-38 2012 273 50/91(55) 12/23(52) 34/66(52) 28/48(58) 34/151(23) 35/122(29) 
TOTAL 189/402(47) 92/247(37) 56/115(49) 41/69(59) 55/202(27) 48/189(25) 
p-value for difference 0.015 0.160 0.682 
 
Results represent number of HAS within each total (%).  Data were only included when results were available for both sides of the equation 
(e.g. proximal and distal); 3 articles with incomplete data are not included. 
 
Unless otherwise stated, proximal arterial locations include internal carotid artery, main-stem of the middle cerebral artery (MCA), vertebral 
and basilar arteries.  Distal arterial locations include sylvian branches of the MCA, and anterior and posterior cerebral arteries. 
 
* Proximal and distal arteries are defined here as internal carotid and middle cerebral arteries, respectively. 
† Thick-slice (5mm) CT data are presented here.  Thin-slice data are also available. 
 
